The Percutaneous Coronary Intervention Market Share Analysis provides the analysis of traders considering their contribution to the overall market. It gives the awareness of its revenue production into the complete market compared to other vendors in the universe. It delivers insights into exactly how dealers are execution in terms of revenue initiation and consumer base compared to others. Knowing market share presents an idea of the size and vendor competitiveness for the base year. It uncovers the market descriptions in terms of growth, breakup, supremacy, and incorporation attributes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Percutaneous Coronary Intervention Market Overview
The global percutaneous coronary intervention market is anticipated to reach USD 16.7 billion by 2020 growing at a CAGR of 7.2% during the forecasting period, 2020-2028. Percutaneous Coronary Intervention is a non-invasive procedure that is used for treating the narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD). Factors such as rising risk factors associated with heart diseases such as obesity, smoking, and substance abuse, fatty foods, etc and rising geriatric and pediatric population are some of the major drivers for the market of percutaneous coronary intervention.
To Understand Business Strategies, Request for a Sample Report at: https://www.delvens.com/get-free-sample/percutaneous-coronary-intervention-market
Key Findings
The global percutaneous coronary intervention market is segmented into type, technique, disease, end-user, and geography.
The type segment is segmented into Balloon Angioplasty, Angioplasty with Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, PTCA Catheters, Embolic Protection Devices (EPDs). Balloon Angioplasty segment is further segmented into Aorta, Iliac Artery, Femoral Artery, Popliteal Artery, Tibial and Peroneal Arteries. Angioplasty with Stent is further segmented into Dual Therapy Stent, Bioresorbable Vascular Scaffold, Bio-Engineered Stent, Drug-Eluting Stent, and bare-metal stent. The Rotational Atherectomy segment is further segmented into Low-Speed Rotational Atherectomy, High-Speed Rotational Atherectomy. CTO (Chronic Total Occlusions) segment is further segmented into Retrograde Technique, Anterograde Technique with Wire Scaling, Anterograde Dissection, and Reentry Technique and Others.
Techniques are segmented into Advanced Imaging, Fractional Flow Reserve (FRR), and Radial Artery Access
The disease is segmented into Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD). Angina is further segmented into Unstable Angina, Stable Angina. Myocardial Infraction is further segmented into Acute Non-ST Elevation Myocardial Infarction, Acute ST-Elevation Myocardial Infarction. Multivessel Coronary Artery Disease is further segmented into Obstructive Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD).
End-User is segmented into Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, and Others
Geographically, the global percutaneous coronary intervention market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Percutaneous Coronary Intervention Market Regional Analysis
North America region is the largest contributor to the percutaneous coronary intervention market in the forecast period 2020-2028.
Percutaneous Coronary Intervention Market Competitive Landscape
· Abbott
· Asahi Intecc Company Limited
· B. Braun Melsungen AG
· Biosensors International Group Ltd.
· Biotronik
· Boston Scientific Corporation
· C. R. Bard Inc.
· Comed B.V.
· Cook
· Cordis
· Medtronic
· Merit Medical System
· Terumo Corporation
· Philips Healthcare
To Grow Your Business Revenue, Make an Inquiry Before Buying at: https://www.delvens.com/Inquire-before-buying/percutaneous-coronary-intervention-market
Percutaneous Coronary Intervention Market Recent Developments
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
- In 2019, Abbott has announced to acquire Cephea Valve Technologies Inc., which is engaged in developing a minimally invasive mitral valve replacement system.
- In 2018, Medtronic has announced the launch of the first 2.0 mm Drug-Eluting Stent in the United States designed to treat patients with small vessels
Reasons to Acquire in the Percutaneous Coronary Intervention Market
- Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
- Gain authentic and granular data access for the percutaneous coronary intervention market so as to understand the trends and the factors involved behind changing market situations
- Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
- In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Direct Purchase of Percutaneous Coronary Intervention Market Report Research Report: https://www.delvens.com/checkout/percutaneous-coronary-intervention-market
Frequently Asked Questions
What are the years considered to study Percutaneous Coronary Intervention Market?
What is the compound annual growth rate (CAGR) of Percutaneous Coronary Intervention Market?
Which region holds the largest market share in Percutaneous Coronary Intervention Market?
Which region is the fastest growing in Percutaneous Coronary Intervention Market?
Who are the major players in Percutaneous Coronary Intervention Market?
Browse Related Reports:
Dental Implants Market – Trends Forecast Till 2030
Dental Implants Market, By Part (Fixture and Abutment), Material (Titanium Implants and Zirconium Implants), Design (Tapered Implants, and Parallel Walled Implants), Type (Root-Form Dental Implants, Parallel-Walled Dental Implants), Price (Premium Implants, Value Implants, Discounted Implants), End User (Hospitals and Clinics, Dental Laboratories, Other Facilities) And Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Medical Cannabis Market – Trends Forecast Till 2030
Medical Cannabis Market, by Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
Bladder Cancer Market – Trends Forecast Till 2030
Bladder Cancer Market, By Type (Transitional Cell Carcinoma, Invasive Bladder Cancer, Superficial Bladder Cancer, Adenocarcinomax, and Other Rare Types), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Radical Cystectomy, and Others), By Diagnosis (Urine Lab Tests, Cystoscopy, Biopsy, Imaging Test, and Others), By End User (Hospital, Clinic, Cancer Care Centers, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
The global percutaneous coronary intervention (PCI) devices market size is expected to reach USD 11.4 billion by 2027 according to a new study by Polaris Market Research.
The factors contributing to the disease include sedentary lifestyle, smoking, obesity, hereditary factors and alcohol usage.
The mortality rate of CAD has been tremendously increasing grabbing the attention for researchers and clinicians globally, With the technological advancements in stent technologies, design of the guide wires, advent of next generation coronary catheters (percutaneous transluminal coronary angioplasty (PTCA), percutaneous transluminal angioplasty (PTA) balloon catheters ), and the availability of coronary guide wires (steel based, nitinol based ) increased the treatment scope of the coronary heart diseases.
The next generation Cath labs offers advanced services and performs interventional therapeutic procedures such as PCI, PTCA, epicardial ablations of ventricular tachycardia, aortic valve replacements and mitral valve repairs.
The number of PCI procedures and other cardiac interventions is substantially increasing with the increase in the cardiovascular diseases globally.
To increase the performance of multi-specialty hospitals, many government and private hospitals are setting up catheterization labs for improved service offerings.
Given that heart problems are a big now owing to the lifestyles that consumers don’t follow, or that it’s hereditary – the IC heart surgeries are affordable of preventing or curing them.
The kind of modus operandi used in the actual process is similar to what doctors use in emergencies, and it also provides fast results.
• Catheter Based Aortic Diseases treatments
• Adult Congenital Heart Diseases
The difference is that in cardio-thoracic, surgeons might apply procedures connected with invasive cardiopulmonary treatment as seen in the coronary bypass surgery, mitral valve replacement, heart transplant, etc., in IC, the procedures are minimally invasive and require catheterization.
Ease of use and faster recoveries
